Solesence, Inc. (SLSN) Earnings Call Transcripts

19 earnings calls from November 2021 to August 19, 2026

NasdaqCM US Materials Chemicals

Solesence, Inc.'s Latest Earnings Call - Q4 FY2025

In the fourth quarter of 2025, Solesence, Inc. (SLSN:US) reported revenue of $12.5 million, which was flat year-over-year, while full-year revenue reached a record $62.1 million, up 18.6% from 2024. The company achieved a net income of $163,000 for the quarter, a significant improvement from a net loss of $558,000 in the prior year. Management has set a gross margin floor of 30% for 2026 and expects to return to double-digit EBITDA as part of their 'Transform and Transcend' initiative, which aims to enhance operational efficiency and profitability moving forward.

Reported metrics

MetricValueContext
Q4 Revenue $12.5 million (inline) vs $12.5 million est, +0% YoY
Full Year Revenue $62.1 million (beat) vs $62 million est, +18.6% YoY
Q4 Gross Profit $3.4 million (positive) vs $2.8 million in Q4 2024
Gross Margin 27% (positive) vs 22% in Q4 2024
Net Income Q4 $163,000 (positive) vs net loss of $558,000 in Q4 2024
Adjusted EBITDA $4.2 million (negative) less than 7% of revenue

Guidance from management

Solesence has set a gross margin floor of 30% for 2026 and expects to return to double-digit EBITDA, while anticipating a normalization period in revenue for the first quarter due to operational investments and customer order changes.

What management said

Thank you, operator, and thank you to our investors, brand partners and teammates who are joining us today. Today, we will provide more guidance on our 2026 plan and the strategy we initiated at the end of 2025, which aims to take our company forward to enhance consumer health and well-being while delivering outstanding results to our investors. This initiative is called Transform and Transcend. Before we delve into ...
— Kevin Cureton, Q4 FY2025 earnings call
Thank you, Tony, and thanks for joining. So what we'll do is have Laura address your first question and also can provide some color on the gross margin area, and then I may offer additional color to that. Laura?
— Kevin Cureton, Q4 FY2025 earnings call

What analysts pressed on

Analysts expressed concerns over the lack of specific EPS guidance for 2026 and the conservative gross margin target compared to previous expectations. There were also questions regarding production struggles and the impact of customer dynamics on future sales.

Main topics on the call

Read the full Solesence, Inc. transcript (Q4 FY2025) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Solesence, Inc.

Solesence, Inc. (SLSN) is a publicly listed company in the Chemicals industry, within the Materials sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 19 calls on record spanning November 4, 2021 to August 19, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 19 Solesence, Inc. earnings call transcripts on record, spanning November 4, 2021 to August 19, 2026. Based on this history, Solesence, Inc. reports quarterly. The most recent call on file is dated August 19, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
SLSN
Exchange
NasdaqCM
Country
US
Sector
Materials
Industry
Chemicals
Calls on record
19
First call
November 4, 2021
Most recent
August 19, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Aug 19, 2026 Read transcript
Q1 FY2026 May 12, 2026 Read transcript
Q4 FY2025 Mar 31, 2026 Read transcript
Q3 FY2025 Nov 11, 2025 Read transcript
Q2 FY2025 Jul 31, 2025 Read transcript
Q4 FY2024 Mar 27, 2025 Read transcript
Q3 FY2024 Oct 31, 2024 Read transcript
Q2 FY2024 Aug 7, 2024 Read transcript
Q1 FY2024 Apr 24, 2024 Read transcript
Q4 FY2023 Mar 21, 2024 Read transcript
Q3 FY2023 Nov 14, 2023 Read transcript
Q2 FY2023 Aug 3, 2023 Read transcript
Q1 FY2023 May 12, 2023 Read transcript
Q4 FY2022 Mar 30, 2023 Read transcript
Q3 FY2022 Nov 9, 2022 Read transcript
Q2 FY2022 Aug 18, 2022 Read transcript
Q1 FY2022 May 12, 2022 Read transcript
Q4 FY2021 Apr 5, 2022 Read transcript
Q3 FY2021 Nov 4, 2021 Read transcript